Discover
01Performance is
our duty
As a preclinical oncology CRO, XenTech believe in expertise, carry innovative values and creative solutions to facilitate and make emerge new efficient tools to fight cancer globally. We’re not in the size or numbers’ race but rather favor precisely targeted tools and services that will provide easier and faster solutions to the oncology research community and ultimately improve patients’ health.
With this spirit we are constantly evolving and prefer focusing on underserved niche (pediatric oncology), accurate models addressing nowadays needs in oncology research (MATCH-R line of PDX reflecting acquired resistance to newly approved or in clinical evaluation drugs) and capitalize on our historic expertise in Breast cancer for which we aim to be THE #1 Reference.
Discover
01They trust us
01Our latest
publications
10.08.21
STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway – Oncogene, Oct.8 2021
Discover
Publications
Paediatric Liver Cancer
A preclinical platform of mouse-transplanted human pediatric liver tumors to evaluate the efficacy of conventional and innovative anticancer therapy
Discover
Publications
Paediatric Liver Cancer
Liver cancer patient-derived xenografts to improve disease management in childhood and adolescence: perspectives and challenges of personalized medicine
Discover
Publications
Paediatric Liver Cancer
A panel of pediatric liver cancer patient-derived xenografts to improve stratification of children with hepatoblastoma
Discover
